Determinant factors for chronic kidney disease after partial nephrectomy

(Rapamycin Press) Minimally invasive surgery appears to offer broader therapeutic scope for the renal masses without compromising oncological outcomes in proper hands.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news

Related Links:

We sincerely appreciate and agree with the Letter to the Editor. Indeed, partial nephrectomy (PN) is undeniably the mainstay treatment for localized renal tumors in the adult population. A significant shift toward increased use of nephron-sparing surgery (NSS) and minimally invasive surgery (MIS) to treat patients with renal cell carcinoma has been clearly documented, and is based on several reasons including similar oncological outcomes, lower risk of chronic kidney disease (CKD) (PN vs radical nephrectomy [RN]), and better postoperative recovery and shorter length of stay (MIS vs open surgery).
Source: Urology - Category: Urology & Nephrology Authors: Source Type: research
We sincerely appreciate and agree with the Letter to the Editor. Indeed, partial nephrectomy (PN) is undeniably the mainstay treatment for localized renal tumors in the adult population. A significant shift toward increased use of nephron-sparing surgery (NSS) and minimally invasive surgery to treat patients with renal cell carcinoma has been clearly documented, and is based on several reasons including similar oncological outcomes, lower risk of chronic kidney disease (PN vs radical nephrectomy) and better postoperative recovery and shorter length of stay (MIS vs open surgery).
Source: Urology - Category: Urology & Nephrology Authors: Tags: Letters to the Editor Source Type: research
We sincerely appreciate and agree with the Letter to the Editor. Indeed, partial nephrectomy (PN) is undeniably the mainstay treatment for localized renal tumors in the adult population. A significant shift toward increased use of nephron-sparing surgery (NSS) and minimally invasive surgery (MIS) to treat patients with renal cell carcinoma has been clearly documented, and is based on several reasons including similar oncological outcomes, lower risk of chronic kidney disease (CKD) (PN vs radical nephrectomy [RN]), and better postoperative recovery and shorter length of stay (MIS vs open surgery).
Source: Urology - Category: Urology & Nephrology Authors: Tags: Letter to the Editor Source Type: research
Publication date: July 2015 Source:Advances in Chronic Kidney Disease, Volume 22, Issue 4 Author(s): Rashed A. Ghandour , Matthew R. Danzig , James M. McKiernan Renal cell carcinoma is the most common cancer of the kidneys that is primarily treated with surgery, including removal of part or all the involved kidney depending on size and tumor, complexity, and patient characteristics. Partial nephrectomy historically was restricted to cases of solitary kidney or bilateral tumors. It was then started for masses smaller than 4 cm and currently is even studied and justified in tumors smaller than 7 cm if surgically ...
Source: Advances in Chronic Kidney Disease - Category: Urology & Nephrology Source Type: research
Conclusions VHL/PBRM1 mutations confirmed 3rd subtype identified and under review but appears to be mis-classified tumors.  Shows value of molecular methods rather than new mechanistic insights. Integration with survival outcome—suggests molecular detailing can be prognostic Full integrative analysis in process Preliminary data can be found at http://tcga-data.nci.hih.gov/tcga/ FoxO Transcription Factors in mTORC1- Activated Renal Tumorigenesis:  Implications for the RCC Treatment Boyi Gan, MD Anderson Cancer Center FoxO Family Transcription Factors:  mammals possess FoxO...
Source: Kidney Cancer Association - Category: Urology & Nephrology Source Type: news
We are grateful to patient advocate Katherine Phillion for sharing her notes from our fall kidney cancer meeting.  Eigth International Kidney Cancer Symposium September 2009     Management of Small Renal Masses and Localized Renal Carcinoma Case Presentation and Background Robert G. Uzzo, M.D., FACS There are a lot of options available to manage small (
Source: Kidney Cancer Association - Category: Urology & Nephrology Source Type: news
  Eighth International Kidney Cancer Symposium September 2009     Management of Small Renal Masses and Localized Renal Carcinoma Case Presentation and Background Robert G. Uzzo, M.D., FACS There are a lot of options available to manage small (
Source: Kidney Cancer Association - Category: Urology & Nephrology Source Type: news
More News: Cancer & Oncology | Chronic Kidney Disease | Minimally Invasive Surgery | Nephrectomy | Urology & Nephrology